Redman BG - Search Results

1

Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.

Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. Redman BG, et al. Clin Cancer Res. 2003 May;9(5):1666-72. Clin Cancer Res. 2003. PMID: 12738719 Clinical Trial.

2

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.

Hellerstedt B, Pienta KJ, Redman BG, Esper P, Dunn R, Fardig J, Olson K, Smith DC. Hellerstedt B, et al. Among authors: redman bg. Cancer. 2003 Oct 15;98(8):1603-10. doi: 10.1002/cncr.11686. Cancer. 2003. PMID: 14534875 Free article. Clinical Trial.

3

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD. Brewer GJ, et al. Among authors: redman bg. Clin Cancer Res. 2000 Jan;6(1):1-10. Clin Cancer Res. 2000. PMID: 10656425 Clinical Trial.

4

Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.

Mackler NJ, Pienta KJ, Dunn RL, Cooney KA, Redman BG, Olson KB, Fardig JE, Smith DC. Mackler NJ, et al. Among authors: redman bg. Clin Genitourin Cancer. 2007 Jun;5(5):318-22. doi: 10.3816/CGC.2007.n.010. Clin Genitourin Cancer. 2007. PMID: 17645828 Clinical Trial.

5

Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.

Redman BG, Chang AE, Whitfield J, Esper P, Jiang G, Braun T, Roessler B, Mulé JJ. Redman BG, et al. J Immunother. 2008 Jul-Aug;31(6):591-8. doi: 10.1097/CJI.0b013e31817fd90b. J Immunother. 2008. PMID: 18528294 Free PMC article. Clinical Trial.

6

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.

Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Smith DC, et al. J Clin Oncol. 1999 Jun;17(6):1664-71. doi: 10.1200/JCO.1999.17.6.1664. J Clin Oncol. 1999. PMID: 10561202 Clinical Trial.

7

A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostate.

Pienta KJ, Redman BG, Esper PS, Flaherty LE. Pienta KJ, et al. Among authors: redman bg. Am J Clin Oncol. 1996 Oct;19(5):500-3. doi: 10.1097/00000421-199610000-00014. Am J Clin Oncol. 1996. PMID: 8823479 Clinical Trial.

8

Supportive care, pain management, and quality of life in advanced prostate cancer.

Esper P, Redman BG. Esper P, et al. Among authors: redman bg. Urol Clin North Am. 1999 May;26(2):375-89. doi: 10.1016/s0094-0143(05)70077-x. Urol Clin North Am. 1999. PMID: 10361560 Review.

9

Initial patterns of care with oral targeted therapies for patients with renal cell carcinoma.

Filson CP, Redman BG, Dunn RL, Miller DC. Filson CP, et al. Among authors: redman bg. Urology. 2011 Apr;77(4):825-830.e1. doi: 10.1016/j.urology.2010.11.003. Epub 2011 Jan 22. Urology. 2011. PMID: 21256539 Free PMC article.

10

Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions.

Trask PC, Esper P, Riba M, Redman B. Trask PC, et al. J Clin Oncol. 2000 Jun;18(11):2316-26. doi: 10.1200/JCO.2000.18.11.2316. J Clin Oncol. 2000. PMID: 10829053 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters